×

Early movers: MSFT, BID, GE, HPQ, NFLX, BP & more

Trader on the floor of the New York Stock Exchange.
Adam Jeffery | CNBC
Trader on the floor of the New York Stock Exchange.

Check out which companies are making headlines before the bell:

Sotheby'sMSG Chief Executive Officer Tad Smith has left that job to take the CEO job at Sotheby's. He'll be replaced on an interim basis at MSG by James Dolan, the president and CEO of MSG parent Cablevision and the Executive Chairman of MSG.

MicrosoftUBS cut earnings estimates for Microsoft, citing weaker than expected PC demand, ongoing mobile challenges, and the impact of foreign currency.

Garmin – Oppenheimer downgraded the GPS device-maker's stock to "perform", citing limited near-term catalysts and tougher competition in the wearables market.

Hanesbrands – Sterne Agee initiated coverage on the clothing maker with a "buy" rating, calling it a "compelling" long-term story.

Tempur Sealy – The mattress maker has responded to criticism from activist investor H Partners, saying it's failed to outline any constructive steps to enhance the company's strategy, and calling on shareholders to vote for its slate of directors. Among other things, H Partners has called for the removal of Chief Executive Officer Mark Sarvary.

Scripps Network Interactive - The media group struck a deal to buy a majority stake in Polish broadcaster TVN for $615 million.

General Electric – GE has agreed to sell GE Capital's consumer lending units in Australia and New Zealand to KKR-led consortium for $6.26 billion.

Medtronic – The company's CoreValve non-invasive heart valve replacement was more effective than surgery after two years, according to study results presented at the American College of Cardiology meeting in San Diego.

Edwards Lifesciences – Edwards saw similarly upbeat results with its own non-invasive heart valve replacement, also presented at that same meeting.

BP – BP will invest $12 billion in Egypt in a project that will produce the equivalent of three billion barrels of oil.

AstraZeneca – The drug company saw mostly positive results in a study of the long-term effects of its heart drug Brilinta. The study found that the drug can cuts the risk of death or another heart attack or stroke by 16 percent.

Hewlett-Packard - A judge gave preliminary approval to the settlement of a lawsuit by Hewlett-Packard shareholders over its ill-fated acquisition of British software firm Autonomy. HP bought Autonomy for more than $11 billion in 2011, but then had to take an $8.8 billion write-off a year later.

Netflix – Netflix was downgraded to "sell" from "hold" at Evercore, pointing to an intensely competitive environment for the video streaming service.

Questions? Comments? Email us at marketinsider@cnbc.com